IntegraSkin GmbH

IntegraSkin (ISK) implement state-of-the-art biomedical analysis tools, cognitive computing, and our disease-relevant data repository to understand the molecular pathophysiology and, thus, improve the treatment efficacy for patients suffering from Chronic Inflammatory Skin Conditions (CISCs). In doing so, we provide services for patients, dermatologists, and the pharmaceutical industry.